| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.76M | - | |
| VP | 79.5K | $703.6K | - | |
| VP | 67.4K | $596.4K | - | |
| VP | 65.1K | $575.9K | - | |
| VP | 56.3K | $498.2K | -449 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Rangwala Reshma71 | EVP &Chief Medical Officer | Sell | 449 | $8.94 | $4,014.06 | -0.8% | - | - | |
| Jan 28, 2026 | Abate Kristin | Chief Accounting Officer | Sell | 50 | $7.03 | $351.50 | -0.2% | +24.3% | - | |
| Jan 21, 2026 | Abate Kristin | Chief Accounting Officer | Sell | 265 | $5.96 | $1,579.40 | -1.2% | - | - | |
| Oct 1, 2025 | Abate Kristin | Chief Accounting Officer | Sell | 362 | $6.30 | $2,279.15 | -3.5% | +17.7% | - | |
| Sep 15, 2025 | Paulson Richard A.80 | President And CEO | Sell | 1,257 | $6.43 | $8,082.51 | -1.5% | +7.2% | - | |
| Sep 15, 2025 | Mano Michael69 | SVP, General Counsel&Secretary | Sell | 234 | $6.43 | $1,504.62 | -1.1% | +7.2% | - | |
| Sep 15, 2025 | Poulton Stuart78 | EVP, Chief Development Officer | Sell | 401 | $6.43 | $2,578.43 | -1.4% | +7.2% | - | |
| Sep 15, 2025 | Rangwala Reshma71 | EVP &Chief Medical Officer | Sell | 408 | $6.43 | $2,623.44 | -1.4% | +7.2% | - | |
| Sep 15, 2025 | Abate Kristin | Chief Accounting Officer | Sell | 23 | $6.43 | $147.89 | -0.2% | +7.2% | - | |
| Sep 15, 2025 | Cheng Sohanya Roshan74 | EVP &Chief Commercial Officer | Sell | 325 | $6.43 | $2,089.75 | -0.9% | +7.2% | - |